Prolactin-releasing peptide

2021 ◽  
pp. 33-36
Author(s):  
Tetsuya Tachibana ◽  
Tatsuya Sakamoto
2007 ◽  
Vol 0 (0) ◽  
pp. 071115085713008-??? ◽  
Author(s):  
Zsuzsanna E. Tóth ◽  
Dóra Zelena ◽  
Zsuzsa Mergl ◽  
Eszter Kirilly ◽  
Péter Várnai ◽  
...  

2012 ◽  
Vol 147 (3-4) ◽  
pp. 170-179 ◽  
Author(s):  
Alex Romero ◽  
René Manríquez ◽  
Claudio Alvarez ◽  
Cristina Gajardo ◽  
Jorge Vásquez ◽  
...  

2002 ◽  
Vol 35 (6) ◽  
pp. 461-470 ◽  
Author(s):  
Kenshi Kakihara ◽  
Norio Iijima ◽  
Yoshihisa Naruse ◽  
Yoshifumi Tanaka ◽  
Yasuhiko Ibata ◽  
...  

2020 ◽  
Vol 2020 (4) ◽  
Author(s):  
Anthony P. Davenport ◽  
Janet J. Maguire ◽  
Edward J. Mead ◽  
Adam J. Pawson

The kisspeptin receptor (nomenclature as agreed by the NC-IUPHAR Subcommittee on the kisspeptin receptor [9]), like neuropeptide FF (NPFF), prolactin-releasing peptide (PrP) and QRFP receptors (provisional nomenclature) responds to endogenous peptides with an arginine-phenylalanine-amide (RFamide) motif. kisspeptin-54 (KP54, originally named metastin), kisspeptin-13 (KP13) and kisspeptin-10 (KP10) are biologically-active peptides cleaved from the KISS1 (Q15726) gene product. Kisspeptins have roles in, for example, cancer metastasis, fertility/puberty regulation and glucose homeostasis.


Sign in / Sign up

Export Citation Format

Share Document